1-4 of 4
Thomas Kästenbauer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Clamp-Like Index: A novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects

Christian Anderwald, MD, MPHARM, Marietta Anderwald-Stadler, MD, Miriam Promintzer, MD, Gerhard Prager, MD, Martina Mandl, MD, Peter Nowotny, Martin G. Bischof, MD, Michael Wolzt, MD, Bernhard Ludvik, MD, Thomas Kästenbauer, DSC, Giovanni Pacini, DSC, Anton Luger, MD, Michael Krebs, MD
Journal: Diabetes Care
Diabetes Care 2007;30(9):2374–2380
https://doi.org/10.2337/dc07-0422
Published: 01 September 2007
View article titled, The Clamp-Like Index: <subtitle>A novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects</subtitle>
Open the PDF for The Clamp-Like Index: <subtitle>A novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects</subtitle> in another window
Includes: Supplementary data
Journal Articles

Lipoprotein(a) as a Predictor of Cardiovascular Disease in a Prospectively Followed Cohort of Patients With Type 1 Diabetes

Barbara Kollerits, MPH, Martin Auinger, MD, Veronika Reisig, MD, Thomas Kästenbauer, PHD, MSC, Arno Lingenhel, PHD, Karl Irsigler, MD, Rudolf Prager, MD, Florian Kronenberg, MD
Journal: Diabetes Care
Diabetes Care 2006;29(7):1661–1663
https://doi.org/10.2337/dc06-0546
Published: 01 July 2006
View article titled, Lipoprotein(a) as a Predictor of Cardiovascular Disease in a Prospectively Followed Cohort of Patients With Type 1 Diabetes
Open the PDF for Lipoprotein(a) as a Predictor of Cardiovascular Disease in a Prospectively Followed Cohort of Patients With Type 1 Diabetes in another window
Journal Articles

Measurement of the Walking Duration With Therapeutic Shoes in Neuropathic Diabetic Patients by a Novel Device (Show-me)

Thomas Kästenbauer, PHD, Johann Wassermann, PHD, Elisabeth Krippl, MD, Rudolf Prager, MD, Karl Irsigler, MD
Journal: Diabetes Care
Diabetes Care 2006;29(6):1456–1465
https://doi.org/10.2337/dc06-0396
Published: 01 June 2006
View article titled, Measurement of the Walking Duration With Therapeutic Shoes in Neuropathic Diabetic Patients by a Novel Device (Show-me)
Open the PDF for Measurement of the Walking Duration With Therapeutic Shoes in Neuropathic Diabetic Patients by a Novel Device (Show-me) in another window
Journal Articles

Increased Plasma Amylin in Type 1 Diabetic Patients After Kidney and Pancreas Transplantation: A sign of impaired β-cell function?

Marietta Stadler, MD, Christian Anderwald, MD, MPHARM, Tina Karer, MD, Andrea Tura, PHD, Thomas Kästenbauer, PHD, Martin Auinger, MD, Christian Bieglmayer, MD, Oswald Wagner, MD, Florian Kronenberg, MD, Peter Nowotny, Giovanni Pacini, DSC, Rudolf Prager, MD
Journal: Diabetes Care
Diabetes Care 2006;29(5):1031–1038
https://doi.org/10.2337/dc05-1247
Published: 01 May 2006
View article titled, Increased Plasma Amylin in Type 1 Diabetic Patients After Kidney and Pancreas Transplantation: <subtitle>A sign of impaired β-cell function?</subtitle>
Open the PDF for Increased Plasma Amylin in Type 1 Diabetic Patients After Kidney and Pancreas Transplantation: <subtitle>A sign of impaired β-cell function?</subtitle> in another window